Mentor Capital targets warrant proceeds for operating cancer companies often like those in the Cancer Immunotherapy Index and to invest in those or related firms via stock purchase or acquisition. The company's advantage is to seek in depth medical science judgment to screen cancer breakthroughs for probable success well in advance of the FDA process. In the Mentor program, an identified cancer company enters into a Long-term Equity Funding Agreement with the company. The company receives cancer...Show all

Mentor Capital targets warrant proceeds for operating cancer companies often like those in the Cancer Immunotherapy Index and to invest in those or related firms via stock purchase or acquisition. The company's advantage is to seek in depth medical s...Show all

See All Exits Recent Exits